Aristotle University Of Thessaloniki (AUTH)
Σύγκριση θεραπευτικών μεθόδων καρκινοποίησης πεδίου για την πρόληψη μη μελανωτικών καρκίνων του δέρματος
Abstract
dc:descriptionBackground: The concept of field cancerization plays an important role in NMSCs. NMSCs the most common skin cancers and the most common cancers in populations worldwide. Skin field cancerization refers to the presence of early invisible changes on photo-damaged skin surrounding the visible AKs. The present study with the three control groups is the first study in Greece and worldwide to investigate and compare PDT treatment protocols in order to prevent the appearance of new NMSC and to retain the prophylactic effect of PDT. 1st CONTROL GROUP. Objectives: To compare efficacy and safety of MAL-PDT vs. IMIQ 5% in the prevention of new NMSCs development patients with field changes. Materials and Methods: Patients with field cancerization of the face or scalp were randomized to receive two sessions of MAL-PDT one week apart on one side. On the mirror field, IMIQ 5% was applied three times per week for two 4-week therapeutic courses with a 2-week treatment-free period between them. The primary endpoint was the number of new lesions on the treated fields during a 12-month follow-up period. Secondary assessments included adverse effects and patient preference. RESULTS: Forty-four patients completed the study. MAL-PDT and IMIQ did not differ concerning the primary endpoint, as there was no statistically significant difference in terms of development of new NMSCs at any point of follow-up. Mean time to occurrence of new lesions was 9.56 ± 2.73 months (95% CI 8.10–11.01) and 10.09 ± 1.97 months (95% CI 8.38–10.36) for the PDT and the IMIQ field, accordingly. Both treatment regimens were safe and well tolerated. Patients' preference based on the procedure, response rates and future choice favored MAL-PDT. CONCLUSIONS: MAL-PDT and IMIQ 5% are safe and well-tolerated treatments that equally prevent development of new AKs in patients suffering from field changes. 2nd CONTROL GROUP. Objectives: To evaluate and compare the safety and the preventive effect in the development of new NMSCs of AFXL-assisted MAL-PDT with one-hour incubation with that of conventional MAL-PDT in patients with clinical and histological signs of field cancerization. Materials and Methods: Fifty patients with two mirror cancerized areas of 50 cm2 of face or scalp were randomized to field treatment with one-hour incubation AFXL-assisted PDT or conventional PDT (CPDT). A session of ultra-pulse fractional CO2 laser (Spectra-SP, MAX Engineering Ltd, South Korea) using scanner handpiece was performed on the entire AFXL-assisted field. Immediately thereafter, MAL cream was applied over both treated areas and was left under occlusion for only one hour in AFXL assisted PDT area and for 3 hours in the CPDT area. Irradiation was performed using a red-light emitting diode lamp at 37 J/cm2. All patients underwent 2 treatment sessions one week apart. Patients were followed up at 3, 6, 9 and 12 months for the evaluation of development of new NMSCs lesions Results: Forty-two patients completed the study. There was no statistically significant difference with respect to the total number of new actinic keratoses at any point of follow-up as well as to the mean time of occurrence of new lesions between treatment fields. Mean time of occurrence of new lesions was 9.55 ±3.02 months (95% CI 8.63 -10.49) for AFXL-PDT and 9.68 ± 2.84 months (95% CI 8.77 10.58) for CPDT. Both treatment regimens were safe and well tolerated. Conclusion: AFXL pretreatment may be considered as an option for reducing photosensitizer occlusion time while providing the same preventative efficacy as CPDT in patients with field cancerized skin. 3rd CONTROL GROUP. Objectives: To determine the optimum time of cyclic CPDT retreatment in order to retain the prophylactic effect in the development of new NMSC. Materials and Methods: Patients with field cancerization of the face or scalp were randomized to receive cyclic CPDT field retreatment in 6 months and in 9 months after the initial PDT treatment. All patients underwent 2 treatment sessions one week apart. Irradiation was performed using a red-light emitting diode lamp at 37 J/cm2. Patients were followed up at 3, 6, 9 and 12 months for the evaluation of development of new NMSCs lesions. Results: Twenty-six patients completed the study. There was no statistically significant difference with respect to the total number of new actinic keratoses at any point of follow-up as well as to the mean time of occurrence of new lesions between treatment fields were 10.125 ± 2.66 months (95% CI 8.71–11.54) at 6 months retreatment and 10.105 ± 2.49 months (95% CI 8.90–11.31). Conclusion: Both retreatments in 6 and 9 months equally prevent the development of new AKs in patients with cancerized fields. The 9 -month interval appears to be the optimum one due to lower cost effect.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vrani, Foteini
- Βράνη, Φωτεινή
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46936